ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,669.75
      1.35%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Arvinas Inc (ARVN)

      7. Arvinas Inc (ARVN) News

      Arvinas Inc

      Arvinas Inc (ARVN)

      NASDAQ
      28.87
      0.25
      (0.87%)
      Closed July 13 4:00PM
      Delayed by 15 minutes
      28.87
      0.00
      (0.00%)
      After Hours: 7:45PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      ARVN News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 18 2024
      ARVN (0.87%)

      Form 3 - Initial statement of beneficial ownership of securities
      Edgar (US Regulatory)
      June 18 2024
      ARVN (0.87%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 18 2024
      ARVN (0.87%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 17 2024
      ARVN (0.87%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 31 2024
      ARVN (0.87%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 30 2024
      ARVN (0.87%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 23 2024
      ARVN (0.87%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 16 2024
      ARVN (0.87%)

      ARVN Discussion

      View Posts
      Monksdream Monksdream 5 months ago
      ARVN new 52=week high
      👍️0
      Monksdream Monksdream 5 months ago
      ARVN new 52 week high
      👍️0
      Monksdream Monksdream 5 months ago
      ARVN new 52 week high
      👍️0
      Monksdream Monksdream 7 months ago
      ARVN new 52 week high
      👍️0
      crudeoil24 crudeoil24 4 years ago
      ARVN up 138% > "Based on data to date, we believe ARV-471 is the most promising ER-targeting therapy in the clinic, showing early signs of efficacy, a favorable tolerability profile, and better ER degradation than that previously reported for fulvestrant, the current standard of care,” said Ron Peck, Ph.D., Chief Medical Officer at Arvinas. “It is exciting to see that ARV-110 continues to be active and well tolerated in what we believe is the most heavily pretreated patient population that has ever been studied with an AR-directed therapy. Our recently initiated ARDENT Phase 2 cohort expansion is specifically designed to investigate the potential of a precision medicine approach in molecularly defined, late-line patients with few available treatment options, while also fully characterizing the safety and activity of ARV-110 in earlier line patients irrespective of molecular profile, setting ARV-110 on a potential two-pronged registrational path.”
      👍️0
      biocqr biocqr 5 years ago
      Advantages of PROTACs vs. inhibition...

      message_id=152832655
      👍️0
      G-lupo G-lupo 5 years ago
      Idk about that, I thought it had some resistance and kept going through, I think at this next convention their going to release some positive news. I’m so holy I didn’t sell at $30 which was ceiling I thought. Do have in a $35 limit sell thought if drops. Rebuy anything under $25
      👍️0
      boo boo boo boo 5 years ago
      Starting to see a chink in the armor!
      👍️0
      G-lupo G-lupo 5 years ago
      Possibly wall at 30.50
      👍️0
      G-lupo G-lupo 5 years ago
      I feel people are going to start taking profits before $35 price target and give it a dip back.
      Question is what is that dip price
      👍️0
      boo boo boo boo 5 years ago
      The offering:

      8-k
      👍️0
      boo boo boo boo 5 years ago
      Benzinga 11/14/2019:

      With a rating of Buy, Roth Capital initiated coverage on Arvinas Inc (NASDAQ:ARVN). The price target is set at $35.00 for Arvinas. In the third quarter, Arvinas showed an EPS of $0.21, compared to ($62.38) from the year-ago quarter. The current market cap for Arvinas is at $696.1 million. The stock has a 52-week-high of $28.96 and a 52-week-low of $10.19. Arvinas's stock last closed at $28.38 per share.

      I might post a chart in about a week, well after everything plays out!
      👍️0
      boo boo boo boo 5 years ago
      It doesn't have to be a PR:

      #8
      👍️0
      G-lupo G-lupo 5 years ago
      Thanks, I’m in it, thought $28 would be resistant and broke through looks may break $30
      👍️0
      boo boo boo boo 5 years ago
      https://polsonnews.com/arvinas-inc-nasdaqarvn-receives-34-33-average-pt-from-brokerages/
      👍️0
      G-lupo G-lupo 5 years ago
      When did they Do a price target announcement? I didn’t see that.
      👍️0
      boo boo boo boo 5 years ago
      If I were in this one (I'm not), I'd be finding the exit on the price target announcement.
      👍️0
      G-lupo G-lupo 5 years ago
      Arvn looking good, defintely see $26-27
      👍️0
      G-lupo G-lupo 5 years ago
      What you mean IBD?
      👍️0
      boo boo boo boo 5 years ago
      Not me. I look for the trade setup. Learned of this one from IBD and have been following...waiting. Missed the opportunity by 1 day. Would've, Should've, Could've...
      👍️0
      G-lupo G-lupo 5 years ago
      I agree I own a decent amount, purchased from $22 down to $15.50. In for the long haul
      👍️0
      boo boo boo boo 5 years ago
      Missing a trade and people who post a purchase at a specific price well after that price has passed.

      The bottom of the prior range (July thru September) is resistance as far as I'm concerned and you have a couple important SMA's around there. And I agree that a break of $27 could lead to a higher price. Wouldn't be as confident if a press release occurred at the same time, but then again depends on what is said.
      👍️0
      G-lupo G-lupo 5 years ago
      What are you talking about ?

      Saw the rebound at $16, going to get probably Around $25-26, if gets there look for resistance to drop back. Like this stock and with more news if breaks $27 could see $60
      👍️0
      boo boo boo boo 5 years ago
      Screwed this one up. More and better content on biotech values board. And no, I don't think this individual bought 'yesterday' and posted about it the day after. That's crap and not credible...POSER!
      👍️0
      boo boo boo boo 5 years ago
      Fook R's!

      EOM
      👍️0
      boo boo boo boo 5 years ago
      Price is at the 100 Lower Linear Regression channel. Do we consolidate here and eventually move north. No position...yet!
      👍️0
      PennyStock Alert PennyStock Alert 5 years ago
      ARVN
      👍️0
      G-lupo G-lupo 5 years ago
      This stock very volatile, no rhyme or reason why it’s been up and down.
      👍️0
      morokoy morokoy 5 years ago
      Las Vegas man 1st in world to use new experimental cancer drug, ARV 101.

      https://www.reviewjournal.com/life/health/las-vegas-man-1st-in-world-to-use-new-experimental-cancer-drug-video-1654750/
      👍️0

      Your Recent History

      NASDAQ
      ARVN
      Arvinas
      Delayed Upgrade Clock